Cargando…
Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry
INTRODUCTION: This study aimed to assess the incidence of hematologic malignancy (HM) among inflammatory arthritis (IA) patients receiving tumor necrosis factor inhibitors (TNFi) compared with the general Turkish population. METHODS: HUR-BIO (Hacettepe University Rheumatology Biologic Registry) is a...
Autores principales: | Duran, Emine, Ozturk, Zeynep Ozge, Bilgin, Emre, Büyükaşık, Yahya, Dizdar, Omer, Yardimci, Gozde Kubra, Farisogullari, Bayram, Özsoy, Zehra, Ayan, Gizem, Uzun, Gullu Sandal, Ekici, Mustafa, Unaldi, Erdinc, Kilic, Levent, Akdoğan, Ali, Karadag, Omer, Bilgen, Şule Apraş, Kiraz, Sedat, Kalyoncu, Umut, Ertenli, Ali Ihsan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326223/ https://www.ncbi.nlm.nih.gov/pubmed/37294405 http://dx.doi.org/10.1007/s40744-023-00563-z |
Ejemplares similares
-
Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience
por: BİLGİN, Emre, et al.
Publicado: (2021) -
Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience
por: KILIÇ, Levent, et al.
Publicado: (2020) -
The impact of antiphospholipid antibodies in Takayasu arteritis
por: FIRAT ŞENTÜRK, Esra, et al.
Publicado: (2022) -
Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid
por: DOGAN, İsmail, et al.
Publicado: (2020) -
Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results
por: Armagan, Berkan, et al.
Publicado: (2018)